Pin Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 34

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $14M

  • Investors
  • 14

Pin Therapeutics General Information

Description

Developer of therapeutic drugs designed to be used for chemical biology-driven protein degradation. The company's drugs utilize the body's natural processes to regulate protein levels using the ubiquitin-proteasome system, enabling doctors to address various diseases, including cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 401, L Fort Halla Vivaldi
  • 46, Wiryeseoil-ro, Sujeong-gu
  • Seongnam, Gyeonggi
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
TMT, Life Sciences, Oncology
Corporate Office
  • Number 401, L Fort Halla Vivaldi
  • 46, Wiryeseoil-ro, Sujeong-gu
  • Seongnam, Gyeonggi
  • South Korea

Pin Therapeutics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pin Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series C) 23-Dec-2024 $14M Completed Pre-Clinical Trials
6. Accelerator/Incubator 16-Dec-2024 Completed Pre-Clinical Trials
5. Later Stage VC 01-Feb-2023 Completed Pre-Clinical Trials
4. Secondary Transaction - Private 01-Sep-2022 Completed Pre-Clinical Trials
3. Later Stage VC (Series B) 20-Feb-2022 Completed Pre-Clinical Trials
2. Later Stage VC (Series A) 14-Mar-2021 $12.7M $17.6M Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 27-Aug-2019 $5M $5M Completed Pre-Clinical Trials
To view Pin Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Pin Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic drugs designed to be used for chemical biology-driven protein degradation. The company's drugs
Drug Discovery
Seongnam, South Korea
34 As of 2024

Watertown, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pin Therapeutics Competitors (1)

One of Pin Therapeutics’s competitors is Kymera Therapeutics, a Formerly VC-backed company based in Watertown, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kymera Therapeutics Formerly VC-backed Watertown, MA
You’re viewing 1 of 1 competitors. Get the full list »

Pin Therapeutics Patents

Pin Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023301691-A1 Compounds and methods for degrading casein kinase 1 alpha Pending 27-Jun-2022

Pin Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pin Therapeutics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
CKD Venture Capital Corporate Venture Capital Minority
Quantam Finance and Acquisition Corporation Minority
Yuanta Investment Venture Capital Minority
Tech Incubator Program for Startups Accelerator/Incubator
DSC Investment Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Pin Therapeutics FAQs

  • When was Pin Therapeutics founded?

    Pin Therapeutics was founded in 2016.

  • Where is Pin Therapeutics headquartered?

    Pin Therapeutics is headquartered in Seongnam, South Korea.

  • What is the size of Pin Therapeutics?

    Pin Therapeutics has 34 total employees.

  • What industry is Pin Therapeutics in?

    Pin Therapeutics’s primary industry is Drug Discovery.

  • Is Pin Therapeutics a private or public company?

    Pin Therapeutics is a Private company.

  • What is Pin Therapeutics’s current revenue?

    The current revenue for Pin Therapeutics is .

  • How much funding has Pin Therapeutics raised over time?

    Pin Therapeutics has raised $48.4M.

  • Who are Pin Therapeutics’s investors?

    CKD Venture Capital, Quantam Finance and Acquisition, Yuanta Investment, Tech Incubator Program for Startups, and DSC Investment are 5 of 14 investors who have invested in Pin Therapeutics.

  • Who are Pin Therapeutics’s competitors?

    Kymera Therapeutics is a competitor of Pin Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »